Reference : Pharma clinics. Le médicament du mois. L'imiquimod (Aldara): un immunomodulateur pour...
Scientific journals : Article
Human health sciences : Dermatology
Pharma clinics. Le médicament du mois. L'imiquimod (Aldara): un immunomodulateur pour la peau.
[en] Pharma clinics. Medication of the month. Imiquimod (Aldara): an immunomodulator for the skin.
Hermanns-Lê, Trinh mailto [Université de Liège - ULg > > Dermatopathologie >]
Nikkels, Arjen mailto [Université de Liège - ULg > > Dermatologie >]
Uhoda, Isabelle [> >]
Petit, L. [> >]
Pierard, Gérald mailto [Université de Liège - ULg > > Dermatopathologie >]
Revue Médicale de Liège
Yes (verified by ORBi)
[en] Adjuvants, Immunologic/pharmacology/therapeutic use ; Aminoquinolines/pharmacology/therapeutic use ; Cytokines/secretion ; Humans ; Macrophages/immunology ; Skin Diseases/drug therapy/immunology
[en] Imiquimod is the first drug of a new therapeutic class encompassing cutaneous immune response modifiers. This molecule induces the synthesis and release of macrophage-related cytokines. It boosts some local immune responses. These properties are used to treat cutaneous viral condylomas. Other prospective therapeutic goals are presently scrutinized.

File(s) associated to this reference

Fulltext file(s):

Open access
IMIQUIMOD ALDARA.pdfNo commentaryPublisher postprint466.99 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.